Denmark
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.47 B
|
Dec. 31, 2023 | USD 81.56 | -2.90% |
|
Denmark |
|
2 |
USD 4.16 B
|
Dec. 31, 2023 | USD 216.88 | 1.28% |
|
Denmark |
|
3 |
USD 741.58 M
|
Dec. 31, 2023 | USD 5.46 | 0.56% |
|
Denmark |
|
4 |
USD 440.88 M
|
Dec. 31, 2023 | USD 131.57 | -1.84% |
|
Denmark |
|
5 |
USD 276.42 M
|
Dec. 31, 2023 | USD 26.62 | -0.36% |
|
Denmark |
|
6 |
USD 241.73 M
|
Dec. 31, 2023 | USD 95.84 | 0.08% |
|
Denmark |
|
7 |
USD 171.11 M
|
Dec. 31, 2023 | USD 54.16 | -1.39% |
|
Denmark |
|
8 |
USD 168.45 M
|
Dec. 31, 2023 | USD 38.89 | 0.23% |
|
Denmark |
|
9 |
USD 117.59 M
|
Sept. 30, 2024 | USD 109.06 | -0.12% |
|
Denmark |
|
10 |
USD 91.78 M
|
Sept. 30, 2024 | USD 18.73 | 1.26% |
|
Denmark |
|
11 |
USD 70.16 M
|
Dec. 31, 2023 | USD 20.15 | -0.78% |
|
Denmark |
|
12 |
USD 67.70 M
|
Dec. 31, 2023 | USD 91.43 | -1.85% |
|
Denmark |
|
13 |
USD 42.64 M
|
June 30, 2024 | USD 70.50 | 0.61% |
|
Denmark |
|
14 |
USD 9.83 M
|
Dec. 31, 2023 | USD 0.20 | -2.77% |
|
Denmark |
|
15 |
USD 5.68 M
|
Dec. 31, 2023 | USD 2.17 | 5.88% |
|
Denmark |
|
16 |
USD 3.06 M
|
Dec. 31, 2023 | USD 0.57 | 1.47% |
|
Denmark |
|
17 |
USD 1.12 M
|
Sept. 30, 2023 | USD 0.78 | 3.05% |
|
Denmark |
The Health Care company in Denmark with the highest Cash and Short-Term Investments is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 4.47 B.
The Health Care company in Denmark with the lowest Cash and Short-Term Investments is Scandinavian Medical Solutions A/S (Copenhagen Stock Exchange: SMSMED.CO) at USD 1.12 M.
The top 10 Health Care companies in Denmark by Cash and Short-Term Investments are Novo Nordisk A/S, Genmab A/S, H. Lundbeck A/S, Ascendis Pharma A/S, Bavarian Nordic A/S, Zealand Pharma A/S, Novozymes A/S, Demant A/S, Coloplast A/S and Ambu A/S.
The bottom 10 Health Care companies in Denmark by Cash and Short-Term Investments are Scandinavian Medical Solutions A/S, Saniona AB (publ), ExpreS2ion Biotech Holding AB (publ), BioPorto A/S, ChemoMetec A/S, Gubra A/S, ALK-Abelló A/S, Ambu A/S, Coloplast A/S and Demant A/S.